Overview

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Status:
Not yet recruiting
Trial end date:
2025-09-20
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin <9 gr/dl , treated with venofer and women treated with ferinject.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Western Galilee Hospital-Nahariya
Treatments:
Ferric Oxide, Saccharated
Criteria
Inclusion Criteria:

pregnancy>24 weeks of gestation anemia with Hb<8 anemia with Hb<9 if symptomatic anemia of
previous postpartum hemorrhage

Exclusion Criteria:

- Allergy to one of the study's drugs

- IV iron treatment in the last month

- chronic anemia- thalassemia, renal failure Twins pregnancy

- non iron deficiency anemia